Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.01 USD | +9.88% | -2.55% | +36.22% |
May. 23 | Cogent Reports Positive Cancer Combo Treatment Trial Data; Names Commercial Chief | MT |
May. 23 | Cogent Biosciences, Inc. Announces the Appointment of Cole Pinnow as Chief Commercial Officer | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 1.18M | Capitalization | 766M |
---|---|---|---|---|---|
Net income 2024 * | -229M | Net income 2025 * | -238M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 650 x |
P/E ratio 2024 * |
-3.57
x | P/E ratio 2025 * |
-3.68
x | Employees | 164 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.93% |
Latest transcript on Cogent Biosciences, Inc.
1 day | +9.88% | ||
1 week | -2.55% | ||
1 month | +23.23% | ||
3 months | +14.43% | ||
6 months | +4.43% | ||
Current year | +36.22% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Robbins
CEO | Chief Executive Officer | 48 | 20-10-22 |
John Green
DFI | Director of Finance/CFO | 43 | 18-05-31 |
Rachael Easton
CTO | Chief Tech/Sci/R&D Officer | - | 22-11-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arlene Morris
BRD | Director/Board Member | 72 | 19-07-25 |
Matthew Ros
BRD | Director/Board Member | 57 | 19-07-25 |
Todd Shegog
BRD | Director/Board Member | 59 | 21-02-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.05% | 234 M€ | +8.48% | - | |
0.04% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 8.01 | +9.88% | 1,380,641 |
24-05-30 | 7.29 | -5.45% | 1,665,386 |
24-05-29 | 7.71 | -8.32% | 1,381,327 |
24-05-28 | 8.41 | +2.31% | 1,252,977 |
24-05-24 | 8.22 | +9.75% | 1,001,724 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.22% | 766M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- COGT Stock